Stockreport

Amphastar: Higher Costs, Lower Growth, And A 'Value Trap' Label [Seeking Alpha]

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations
PDF AMPH's legacy generics are declining, branded products face growth deceleration, and margins are pressured by product mix and rising R&D/SG&A costs. FY26 revenue guid [Read more]